Jacob T. Williams

Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma

Lynette M. Smith, S. Holstein, S. Haney, 2019, Experimental Hematology & Oncology.

The Peptide–Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death

A. Slipicevic, S. Holstein, C. Heckman, 2022, HemaSphere.

Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma

Lynette M. Smith, S. Holstein, D. Murry, 2022, Drug development research.

Investigation of the activity of a novel tropolone in osteosarcoma

S. Haney, M. Varney, Y. Chhonker, 2023, Drug development research.